Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for posttraumatic stress disorder (PTSD) puts the therapy's near-term future in doubt ...

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the ...

then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

Two small studies submitted to the FDA suggested combining MDMA with talk therapy led to significant easing of PTSD symptoms. Antidepressants are now the only FDA-approved drugs for PTSD ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...